ProfoundBio Email Format
Biotechnology ResearchWashington, United States51-200 Employees
This page will no longer be active or monitored. For updates on our work, please follow Genmab at: https://bit.ly/3Kf80df. ProfoundBio is now part of Genmab. As part of Genmab, we are looking forward to continuing our work of developing novel antibody-based therapeutics for patients with cancer.